Spironolactone
- Product NDC
- 0615-1535
- 11-digit product format
- 006151535
- Labeler code
- 0615
- Product ID
- 0615-1535_c811c81f-84d9-4d55-bbd4-2b30a6e5a32d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- spironolactone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA040424
- Marketing category
- ANDA
- Marketing start
- 2001-08-20
- Marketing end
- 0000-00-00
- Substance
- SPIRONOLACTONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-1535-05 | 2021-09-03 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |
| 0615-1535-31 | 2021-09-03 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |
| 0615-1535-39 | 2021-09-03 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |
| 0615-1535-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |
| 0615-1535-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |
| 0615-1535-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e15b-f424-e053-dadaa90a57ce | 7d16b436-c76c-4ac8-b36a-149a14faecab |